thcfreecbd.shop

APAC Laws by Country — THC‑Free CBD 2025

This quick‑reference page summarizes conservative, high‑level notes on how selected Asia–Pacific jurisdictions treat CBD products marketed as “THC‑free.” It is not legal advice. Policies change and enforcement can be strict; always verify with current laws, regulator notices, and customs guidance before acting.

On this page

What “THC‑free” means here

“THC‑free” is a laboratory reporting outcome (for example, Δ9‑THC reported as Not Detected at the lab’s Limit of Quantitation, LOQ). It is not a legal category and does not itself create retail, import, or possession pathways. See LOQ vs LOD and How to Read COAs.

How to use this page

Start with the quick note for your destination, then follow links to detailed country pages (where available). Always corroborate with the competent authority (health/medicines regulator, narcotics authority, and customs) before any action.

East Asia

  • Japan: Highly constrained; THC remains prohibited. CBD permissibility depends on precise composition and current guidance. See Japan overview.
  • South Korea: Strict narcotics controls; narrow medical precedents only. Consumer retail pathways are heavily constrained. See South Korea overview.
  • Taiwan: Restricted landscape; do not assume OTC consumer permissibility. Verify with MOHW/TFDA. See Taiwan overview.
  • Hong Kong: Total ban on CBD since 2023; possession, import, supply, or transit prohibited regardless of “THC‑free” claims. See Hong Kong overview.
  • China (Mainland): Very strict; CBD barred from cosmetics since 2021; no recognized consumer pathway. See China overview.
  • Macau: Treat consumer CBD as prohibited or highly restricted absent a clear official pathway. See Macau overview.

Southeast Asia

  • Singapore: Very strict; do not ship or carry CBD; penalties can be severe. See Singapore overview.
  • Thailand: Policy in flux since 2022; category‑dependent rules and ongoing proposals to tighten controls. See Thailand overview.
  • Vietnam: Very strict; treat consumer CBD as prohibited. See Vietnam overview.
  • Malaysia: Strict/controlled; do not assume retail/mail‑order permissibility. See Malaysia overview.
  • Philippines: Conservative posture; verify with DOH/FDA Philippines, DDB, PDEA, and customs. See Philippines overview.
  • Indonesia: Very strict narcotics framework; no consumer retail or postal pathway. See Indonesia overview.
  • Cambodia: Treat consumer CBD as prohibited absent a clearly published pathway. See Cambodia overview.
  • Other SEA jurisdictions (e.g., Brunei, Laos, Myanmar): Often strict; do not assume permissibility; verify locally before any action.

South Asia

  • India: Complex and conservative; limited medical/AYUSH contexts referenced; no general consumer retail pathway. See India overview.
  • Other South Asia (e.g., Pakistan, Bangladesh, Sri Lanka, Nepal): Rules vary; assume strict unless an official pathway is clearly published. Verify locally.

Oceania

  • Australia: Prescription‑oriented framework with specific scheduling; advertising/claims tightly controlled. See Australia overview.
  • New Zealand: Many CBD products treated as prescription medicines; quality standards apply. See New Zealand overview.

Travel, imports, and mail — risk reminders

  • “THC‑free” labeling or an ND‑THC COA does not create a legal import, retail, or possession pathway.
  • Expect strict enforcement in many APAC jurisdictions, including inspections and product testing.
  • International travel with CBD is high‑risk in APAC. Review International Travel Guidelines and destination‑specific pages.

How to verify quickly

  1. Locate official regulator websites (health/medicines, narcotics, and customs) and search for CBD/cannabis notices updated in 2024–2025.
  2. Confirm product category (medicine, cosmetic, food, vape, etc.); categories follow different pathways.
  3. Review a batch‑matched COA for any product you consider; ND at LOQ is not a permission slip. See How to Read COAs.
  4. When in doubt, avoid shipment or travel and consult local authorities directly.

FAQ

Is CBD legal across APAC?
No. Enforcement ranges from total bans (e.g., Hong Kong) to narrow prescription frameworks (e.g., Australia, New Zealand) and evolving contexts (e.g., Japan, Thailand). Always verify locally.

Does “THC‑free” on a COA make a product legal to sell or carry?
No. “THC‑free” is a lab outcome (ND at LOQ), not a legal classification.

Can I ship or bring CBD into APAC if it is THC‑free?
Often no. Many jurisdictions prohibit imports and possession regardless of “THC‑free” claims. Review the country page and consult customs.

Where can I find deeper details?
Use the country links above and the APAC Overview. For travel mechanics, see International Travel Guidelines.